Literature DB >> 9706773

Extrahepatic biliary obstruction by metastatic gastric carcinoma.

K M Chu1, S Law, F J Branicki, J Wong.   

Abstract

Forty-one patients with extrahepatic biliary obstruction by metastatic gastric carcinoma underwent retrospective study to determine demographics, clinical features, laboratory findings on presentation, time interval from previous gastrectomy, level of biliary obstruction, methods of palliation, complications from treatment, treatment results, and survival. Thirty-seven patients underwent biliary decompression by percutaneous transhepatic biliary drainage (PTBD) (35 patients), endoscopic insertion of plastic stent (one patient), and operative insertion of T tube (1 patient). The remaining 4 patients had no biliary drainage procedure performed. Subsequently expandable metallic biliary stents were inserted in 9 patients through the PTBD tract. Two patients received postdrainage external irradiation. Reduction in serum total bilirubin was seen in all patients after drainage. Two patients were alive at the time of this analysis. The median survival of these 41 patients was only 70 days. The 6- and 9-month survival rates were 27.0% and 9.7%, respectively. Hemoglobin (p < 0.001) and total bilirubin (p < 0.002) on presentation were found to be independent factors predicting survival. Extrahepatic biliary obstruction by metastatic gastric carcinoma was associated with poor survival. Patients with profound anemia or jaundice on presentation carried the worst prognosis.

Entities:  

Mesh:

Year:  1998        PMID: 9706773     DOI: 10.1097/00004836-199807000-00013

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  8 in total

1.  Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma.

Authors:  Abeezar I Sarela; Thomas J Miner; Martin S Karpeh; Daniel G Coit; David P Jaques; Murray F Brennan
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

2.  Clinical outcome of malignant biliary obstruction caused by metastatic gastric cancer.

Authors:  Kazuhiro Migita; Akihiko Watanabe; Tetsuya Yoshioka; Shoichi Kinoshita; Takao Ohyama
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

3.  Efficacy and safety of covered self-expandable metal stents for management of distal malignant biliary obstruction due to lymph node metastases.

Authors:  Kazumichi Kawakubo; Hiroyuki Isayama; Yousuke Nakai; Osamu Togawa; Naoki Sasahira; Hirofumi Kogure; Takashi Sasaki; Saburo Matsubara; Natsuyo Yamamoto; Kenji Hirano; Takeshi Tsujino; Nobuo Toda; Minoru Tada; Masao Omata; Kazuhiko Koike
Journal:  Surg Endosc       Date:  2011-04-13       Impact factor: 4.584

4.  Biliary intraductal metastasis from advanced gastric cancer: radiologic and histologic characteristics, and clinical outcomes of percutaneous metallic stent placement.

Authors:  JooYeon Lee; Dong Il Gwon; Gi-Young Ko; Jong Woo Kim; Kyu-Bo Sung
Journal:  Eur Radiol       Date:  2015-09-17       Impact factor: 5.315

5.  Gastric adenocarcinoma causing biliary obstruction without ductal dilatation: a case report.

Authors:  Karl Vaz; Raphael P Luber; Catriona McLean; Jan Frank Gerstenmaier; Stuart K Roberts
Journal:  J Med Case Rep       Date:  2019-03-09

6.  Surgical treatment of ductal biliary recurrence of poorly cohesive gastric cancer mimicking primary biliary tract cancer: a case report.

Authors:  Edoardo Poletto; Andrea Ruzzenente; Giulia Turri; Simone Conci; Serena Ammendola; Claudio Luchini; Aldo Scarpa; Alfredo Guglielmi
Journal:  J Surg Case Rep       Date:  2022-04-11

7.  Percutaneous placement of self-expandable metallic stents in patients with obstructive jaundice secondary to metastatic gastric cancer after gastrectomy.

Authors:  Hyun Pyo Hong; Tae-Seok Seo; In-Ho Cha; Jung Rim Yu; Young Jae Mok; Joo Hyeong Oh; Se Hwan Kwon; Sam Soo Kim; Seung Kwon Kim
Journal:  Korean J Radiol       Date:  2013-08-30       Impact factor: 3.500

8.  Clinical outcomes and prediction of survival following percutaneous biliary drainage for malignant obstructive jaundice.

Authors:  Guang Yuan Zhang; Wen Tao Li; Wei Jun Peng; Guo Dong Li; Xin Hong He; Li Chao Xu
Journal:  Oncol Lett       Date:  2014-02-07       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.